


Ask a doctor about a prescription for GLIMEPIRIDE KERN PHARMA 4 mg TABLETS
PACKAGE LEAFLET: INFORMATION FOR THE USER
Glimepiride Kern Pharma 4 mg tablets EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack:
Glimepiride belongs to a group of medicines called oral antidiabetics, which reduce blood sugar levels to normal levels in patients with adult diabetes (type 2 diabetes).
This medicine is prescribed to treat adult diabetes (type 2 diabetes) when diet, physical exercise, and weight reduction alone are not adequate.
Do not take Glimepiride Kern Pharma
Warnings and precautions
Consult your doctor or pharmacist before starting to take your medicine:
It may happen that hemoglobin levels decrease and hemolytic anemia (breakdown of red blood cells) occurs in patients who lack an enzyme called glucose-6-phosphate dehydrogenase.
Important information about hypoglycemia (low blood sugar)
If you are taking glimepiride, you may experience hypoglycemia (low blood sugar). Please see below for more information about hypoglycemia, its signs, and treatment.
The following factors can increase the risk of you experiencing hypoglycemia:
The signs of hypoglycemia include:
If your blood sugar levels continue to drop, you may experience considerable confusion (delirium), have convulsions, lose self-control, have shallow breathing and a slower heart rate, and may become unconscious. The clinical picture of a severe drop in blood sugar is similar to a stroke.
Treatment of hypoglycemia
In most cases, the symptoms of low blood sugar disappear quickly when you take something sweet, such as sugar cubes, sweet juices, sugary tea.
Therefore, you should always carry something sweet with you (e.g., sugar cubes). Remember that artificial sweeteners are not effective. Please consult your doctor or go to the hospital if you do not recover after taking sugar or if the symptoms recur.
Blood tests
Your blood sugar and urine levels should be regularly checked. Your doctor may ask for blood tests to check the number of blood cells and how your liver is working.
Use of other medicines
Tell your doctor or pharmacist if you are using or have recently used any other medicines, including those obtained without a prescription, as it may be necessary to interrupt treatment or adjust the dose of one of them.
If you take glimepiride with the following compounds, hypoglycemia (low blood sugar) may occur:
If you take glimepiride with the following compounds, hyperglycemia (high blood sugar) may occur:
If you take glimepiride with the following compounds, both hypoglycemia and hyperglycemia may occur:
Glimepiride may also increase or decrease the effects of the following medicines:
Taking Glimepiride Kern Pharma with food and drinks
Consuming alcohol may increase or decrease the hypoglycemic effect of this medicine in an unpredictable way.
Glimepiride should be taken shortly before or during a meal.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Pregnancy
Glimepiride should not be taken during pregnancy. Consult your doctor if you are pregnant, think you may be pregnant, or are planning to have a baby.
Breastfeeding
Glimepiride may pass into breast milk. Glimepiride should not be used during breastfeeding.
Driving and using machines:
Consult your doctor or pharmacist before using any medicine.
Your ability to concentrate and react may be impaired due to the symptoms caused by hypoglycemia or hyperglycemia, such as vision disturbances.
This can be dangerous in situations where these skills are important (e.g., driving or using machines). Therefore, consult your doctor if it is advisable to drive or use machines.
Important information about some of the ingredients of Glimepiride Kern Pharma
This medicine contains lactose. If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.
Follow exactly the instructions for administration of this medicine given by your doctor. Consult your doctor or pharmacist if you have any doubts.
Remember to take your medicine.
The basis of satisfactory treatment of diabetes is a good diet, regular physical activity, and regular checks of blood and urine. The negative effects that result from not maintaining the diet cannot be compensated for with tablets or insulin.
The dosage is based on the results of the metabolic examination (determinations of glucose in blood and urine).
The initial dose is 1 mg of glimepiride per day orally. In case of good regulation, this same dose may be used as maintenance treatment.
If the regulation is not satisfactory, your doctor will indicate a gradual increase in the dose up to 2, 3, or 4 mg of glimepiride per day.
Only in exceptional cases is it recommended to take more than 4 mg of glimepiride per day, with a maximum recommended dose of 6 mg of glimepiride per day.
If you experience a hypoglycemic reaction after taking a single dose of 1 mg of glimepiride, inform your doctor, as you may probably be regulated only with diet.
During treatment with glimepiride, it is possible that the dose you need may decrease. Therefore, your doctor may need to adjust the daily dose according to your needs and even interrupt treatment.
If you are being treated with metformin and do not achieve adequate metabolic control, your doctor may complement treatment with glimepiride. To do this, they will indicate the necessary dose of glimepiride to use with metformin.
Your doctor will decide if you need to complement glimepiride treatment with insulin. In this case, they will indicate the dose of insulin you should use with glimepiride tablets.
If you think the effect of glimepiride is too strong or too weak, tell your doctor or pharmacist.
The glimepiride tablets should be swallowed without chewing, with a little liquid.
Normally, a single daily dose of glimepiride is sufficient. It is recommended that you take this dose shortly before or during a large breakfast or, if you do not have breakfast, shortly before or during the first meal.
Your doctor will indicate the duration of your treatment with Glimepiride Kern Pharma. Do not stop your treatment before this, as your blood sugar level may become unbalanced again.
Use in children
Glimepiride Kern Pharma has not been studied in children.
Elderly people
No specific studies have been conducted in elderly people.
Due to the fact that biological functions may be decreased, your doctor will adjust the dose with greater caution and more intense monitoring will be necessary.
If you take more Glimepiride Kern Pharma than you should
You may experience an excessive reduction in blood sugar (see "Warnings and precautions") that can last from 12 to 72 hours and may even recur after an initial recovery. The symptoms may appear even 24 hours after ingestion. If this happens, go to the doctor or the emergency department of the nearest hospital, taking this leaflet with you.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount ingested.
If you forget to take Glimepiride Kern Pharma
Do not take a double dose to make up for forgotten doses.
If you stop taking Glimepiride Kern Pharma
If you stop or interrupt treatment, you should keep in mind that the desired effect of reducing blood sugar will not be achieved or that the disease will worsen again. Continue taking glimepiride until your doctor tells you to stop.
If you have any other questions about the use of this product, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
Consult your doctor immediately if you suffer from any of the following symptoms:
Some patients have suffered the following adverse effects while taking glimepiride:
Rare Adverse Effects(affect up to 1 in 1,000 people)
These alterations usually disappear when treatment with glimepiride is discontinued.
Very Rare Adverse Effects(affect up to 1 in 10,000 people)
Other Adverse Effects Include:
Reporting Adverse Effects:
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that is not listed in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines http://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
No special storage conditions are required.
Keep this medicine out of sight and reach of children.
Do not use this medicine after the expiration date shown on the packaging after "CAD". The expiration date is the last day of the month indicated.
Medicines should not be disposed of through wastewater or household waste. Deposit the packaging and unused medicines at the SIGRE Point in the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and unused medicines. This way, you will help protect the environment.
Composition of Glimepirida Kern Pharma
Appearance of the Product and Packaging Content
Glimepirida Kern Pharma 4 mg is presented in the form of oblong tablets, blue in color, and scored on both sides. Each package contains 30 or 120 tablets (standard package), or 500 tablets (clinical package).
Other presentations:
Glimepirida Kern Pharma 2 mg tablets EFG. Standard packages of 30 or 120 tablets, or clinical package of 500 tablets.
Marketing Authorization Holder
Kern Pharma, S.L.
Venus, 72 – Pol. Ind. Colón II
08228 Terrassa – Barcelona
Manufacturer
Edmond Pharma S.R.L.
Strada Statale dei Giovi No. 131
20037 Paderno Dugnano
Milan (Italy)
or
Kern Pharma, S.L.
Venus, 72 - Pol. Ind. Colón II
08228 Terrassa - Barcelona
Spain
Date of the Last Revision of this Prospectus: June 2015
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/.
The average price of GLIMEPIRIDE KERN PHARMA 4 mg TABLETS in November, 2025 is around 20.36 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for GLIMEPIRIDE KERN PHARMA 4 mg TABLETS – subject to medical assessment and local rules.